Download Files:
Products Details
Product Description
– BTK-IN-6 is a potent inhibitor of Bruton’s Tyrosine Kinase (BTK). BTK is a member of the Tec family of tyrosine kinases and plays an important role in the regulation of early B-cell development and mature B-cell activation and survival. BTK-IN-6 has the potential for the research of immune disorders, cancer, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders, and neurological disorders (extracted from patent WO2021136219A1, compound 8)[1].
Web ID
– HY-142932
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C23H22FN5O3
References
– [1]Quan Zhou, et al. Btk inhibitors. Patent WO2021136219A1.
CAS Number
– 2662512-08-3
Molecular Weight
– 435.45
SMILES
– NC1=NC=NN2C([C@H]3CC[C@H](OC3)CO)=NC(C4=C(C=C(C=C4)OC5=CC=CC=C5)F)=C12
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Btk
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
